Dr. Reiser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1611 W. Harrison Street
Suite 510
Chicago, IL 60612Phone+1 312-942-6639Fax+1 312-942-5271
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2003 - 2005
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2000 - 2003
- University of Heidelberg Faculty of MedicineClass of 1998
Certifications & Licensure
- IL State Medical License 2013 - 2026
- TX State Medical License 2023 - 2024
- FL State Medical License 2008 - 2013
- MA State Medical License 2005 - 2010
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2009
Clinical Trials
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
- KIDney Injury in Times of COVID-19 (KIDCOV) Start of enrollment: 2021 Mar 01
Publications & Presentations
PubMed
- 782 citationsRearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell linesPeter Mundel, Jochen Reiser, Aimée Zúñiga Mejı́a Borja, Hermann Pavenstädt, Gary Davidson
Experimental Cell Research. 1997-10-10 - 187 citationsDirect dynamin–actin interactions regulate the actin cytoskeletonChangkyu Gu, Suma Yaddanapudi, Astrid Weins, Teresia Osborn, Jochen Reiser
The EMBO Journal. 2010-11-03 - 106 citationsPodocyte-Specific Overexpression of Wild Type or Mutant Trpc6 in Mice Is Sufficient to Cause Glomerular DiseasePaola Krall, Cesar P. Canales, Pamela Kairath, Paulina Carmona-Mora, Jessica Molina
Plos One. 2010-09-20
Journal Articles
- Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USKusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Alexandre M Shehata, Nitender G..., JAMA Internal Medicine
- Soluble Urokinase Plasminogen Activator Receptor (suPAR) Is Predictive of Non-AIDS Events During Antiretroviral Therapy-Mediated Viral SuppressionMichael M Lederman, Jochen Reiser, Clinical Infectious Diseases
Authored Content
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
- Soluble Urokinase Receptor and Acute Kidney InjuryJanuary 2020
- Join now to see all
Press Mentions
- 87 Industry Leaders Reveal Their Secrets to Elevating Patient CareAugust 29th, 2024
- Scientists Discover New Immune Target to Treat Cardiovascular DiseaseDecember 16th, 2022
- Study Uncovers New Immune Target to Treat AtherosclerosisDecember 16th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: